Compare PALI & TRGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PALI | TRGS |
|---|---|---|
| Founded | 1996 | 2025 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 249.2M | 260.8M |
| IPO Year | 2019 | 2026 |
| Metric | PALI | TRGS |
|---|---|---|
| Price | $0.85 | $10.01 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $8.70 | N/A |
| AVG Volume (30 Days) | ★ 2.9M | 28.4K |
| Earning Date | 11-10-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 97.06 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $260,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 1500.39 | N/A |
| 52 Week Low | $0.92 | $9.88 |
| 52 Week High | $2.86 | $10.03 |
| Indicator | PALI | TRGS |
|---|---|---|
| Relative Strength Index (RSI) | 26.05 | 61.74 |
| Support Level | N/A | N/A |
| Resistance Level | $2.18 | $10.03 |
| Average True Range (ATR) | 0.08 | 0.00 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 0.24 | 76.92 |
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
TRG Latin America Acquisitions Corp is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.